Cellular Biomedicine Group Reports Third Quarter Financial Results and Recent Operational Highlights
Nov 08, 2016 21:15 pm UTC| Business
SHANGHAI, China and CUPERTINO, Calif., Nov. 08, 2016 -- Cellular Biomedicine Group Inc. (NASDAQ:CBMG) (“CBMG” or the “Company”), a clinical-stage biomedicine firm engaged in the development of immunotherapies for cancer...
Adaptimmune Announces Appointment of Tal Zaks to Board of Directors
Nov 08, 2016 21:15 pm UTC| Business
PHILADELPHIA and OXFORD, United Kingdom, Nov. 08, 2016 -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, today announced the appointment of Tal Zaks, M.D., Ph.D., to its Board of...
HealthEquity to Present at Piper Jaffray Healthcare Conferences
Nov 08, 2016 21:10 pm UTC| Business
DRAPER, Utah, Nov. 08, 2016 -- HealthEquity, Inc. (NASDAQ:HQY) (“HealthEquity” or the “Company”), one of the largest HSA non-bank custodians, today announced it will present at the 28th Annual Piper Jaffray Healthcare...
AGTC Announces Financial Results and Business Update for the Quarter Ended September 30, 2016
Nov 08, 2016 21:09 pm UTC| Business
GAINESVILLE, Fla., and CAMBRIDGE, Mass., Nov. 08, 2016 -- Applied Genetic Technologies Corporation (NASDAQ:AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene...
Paragon Offshore Reports Third Quarter 2016 Results and Provides Fleet Status Report
Nov 08, 2016 21:06 pm UTC| Business
Third quarter 2016 revenues of $125 million; net loss of $64 million or $0.72 per shareAdjusted EBITDA of $21 million net of reorganization itemsContract drilling services costs seven percent lower compared to previous...
Rightside® Announces Third Quarter 2016 Financial Results
Nov 08, 2016 21:06 pm UTC| Business
KIRKLAND, Wash., Nov. 08, 2016 -- Rightside Group, Ltd. (Nasdaq:NAME), a leading provider of domain name services that advance the way businesses and consumers define and present themselves online, today announced...
Codexis Reports Financial Results for the Third Quarter of 2016
Nov 08, 2016 21:06 pm UTC| Business
Revenues of $14.9 million driven by core biocatalyst product sales increase of 123%and include $8.0 million milestone revenue from Merck Conference call begins at 4:30 p.m. Eastern time today REDWOOD CITY, Calif. , Nov....